risperidone has been researched along with Mucopolysaccharidosis III in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Mucopolysaccharidosis III: Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the case of a 16-year-old male with Mucopolysaccharidosis III type A (Sanfilippo syndrome) who was commenced on risperidone for behaviour management." | 3.75 | Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III. ( Sillence, D; Tchan, MC, 2009) |
| "Mucopolysaccharidosis IIIA (MPS IIIA) is a lysosomal storage disorder characterized by progressive mental deterioration and severe behavioral problems." | 2.75 | Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status. ( Coker, M; Demiral, N; Erermis, S; Kalkan Ucar, S; Ozbaran, B; Yuncu, Z, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalkan Ucar, S | 1 |
| Ozbaran, B | 1 |
| Demiral, N | 1 |
| Yuncu, Z | 1 |
| Erermis, S | 1 |
| Coker, M | 1 |
| Tchan, MC | 1 |
| Sillence, D | 1 |
1 trial available for risperidone and Mucopolysaccharidosis III
| Article | Year |
|---|---|
Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status.
Topics: Adolescent; Antipsychotic Agents; Child; Child Behavior Disorders; Child, Preschool; Cross-Over Stud | 2010 |
1 other study available for risperidone and Mucopolysaccharidosis III
| Article | Year |
|---|---|
Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III.
Topics: Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; C | 2009 |